• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过C末端蛋白酶体切割位点侧翼的单个氨基酸取代消除CTL表位加工。

Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.

作者信息

Beekman N J, van Veelen P A, van Hall T, Neisig A, Sijts A, Camps M, Kloetzel P M, Neefjes J J, Melief C J, Ossendorp F

机构信息

Department of Immunohematology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

J Immunol. 2000 Feb 15;164(4):1898-905. doi: 10.4049/jimmunol.164.4.1898.

DOI:10.4049/jimmunol.164.4.1898
PMID:10657639
Abstract

CTL directed against the Moloney murine leukemia virus (MuLV) epitope SSWDFITV recognize Moloney MuLV-induced tumor cells, but do not recognize cells transformed by the closely related Friend MuLV. The potential Friend MuLV epitope has strong sequence homology with Moloney MuLV and only differs in one amino acid within the CTL epitope and one amino acid just outside the epitope. We now show that failure to recognize Friend MuLV-transformed tumor cells is based on a defect in proteasome-mediated processing of the Friend epitope which is due to a single amino acid substitution (N-->D) immediately flanking the C-terminal anchor residue of the epitope. Proteasome-mediated digestion analysis of a synthetic 26-mer peptide derived from the Friend sequence shows that cleavage takes place predominantly C-terminal of D, instead of V as is the case for the Moloney MuLV sequence. Therefore, the C terminus of the epitope is not properly generated. Epitope-containing peptide fragments extended with an additional C-terminal D are not efficiently translocated by TAP and do not show significant binding affinity to MHC class I-Kb molecules. Thus, a potential CTL epitope present in the Friend virus sequence is not properly processed and presented because of a natural flanking aspartic acid that obliterates the correct C-terminal cleavage site. This constitutes a novel way to subvert proteasome-mediated generation of proper antigenic peptide fragments.

摘要

针对莫洛尼鼠白血病病毒(MuLV)表位SSWDFITV的细胞毒性T淋巴细胞(CTL)可识别莫洛尼MuLV诱导的肿瘤细胞,但不能识别由密切相关的弗瑞德MuLV转化的细胞。潜在的弗瑞德MuLV表位与莫洛尼MuLV具有很强的序列同源性,仅在CTL表位内的一个氨基酸以及表位外的一个氨基酸上有所不同。我们现在表明,无法识别弗瑞德MuLV转化的肿瘤细胞是基于蛋白酶体介导的弗瑞德表位加工缺陷,这是由于表位C末端锚定残基紧邻的单个氨基酸取代(N→D)所致。对源自弗瑞德序列的合成26肽进行蛋白酶体介导的消化分析表明,切割主要发生在D的C末端,而不是莫洛尼MuLV序列中的V的C末端。因此,表位的C末端没有正确生成。额外带有C末端D的含表位肽片段不能被抗原加工相关转运体(TAP)有效转运,并且对MHC I类Kb分子没有显著的结合亲和力。因此,由于天然存在的侧翼天冬氨酸消除了正确的C末端切割位点,弗瑞德病毒序列中存在的潜在CTL表位没有被正确加工和呈递。这构成了一种颠覆蛋白酶体介导的合适抗原肽片段生成的新方式。

相似文献

1
Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.通过C末端蛋白酶体切割位点侧翼的单个氨基酸取代消除CTL表位加工。
J Immunol. 2000 Feb 15;164(4):1898-905. doi: 10.4049/jimmunol.164.4.1898.
2
Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.从Friend、莫洛尼和劳舍尔鼠白血病病毒诱导的肿瘤中鉴定出FBL-3白血病中由gag编码的细胞毒性T淋巴细胞表位,该表位为上述三种病毒所共有。
J Virol. 1996 Nov;70(11):7773-82. doi: 10.1128/JVI.70.11.7773-7782.1996.
3
A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation.病毒细胞毒性T淋巴细胞(CTL)表位内的单个残基交换会改变蛋白酶体介导的降解,导致抗原呈递缺失。
Immunity. 1996 Aug;5(2):115-24. doi: 10.1016/s1074-7613(00)80488-4.
4
Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice.鉴定一种由H-2 Kb呈递的莫洛尼鼠白血病病毒细胞毒性T淋巴细胞表位,该表位在H-2 Db突变体bm13小鼠中表现出增强的识别能力。
J Virol. 1994 Sep;68(9):6038-46. doi: 10.1128/JVI.68.9.6038-6046.1994.
5
A single amino acid variation within an immunodominant AKR/Gross MuLV cytotoxic T-lymphocyte epitope leads to a loss in immunogenicity.免疫显性AKR/Gross小鼠白血病病毒细胞毒性T淋巴细胞表位内的单个氨基酸变异导致免疫原性丧失。
Viral Immunol. 1998;11(4):197-213. doi: 10.1089/vim.1998.11.197.
6
Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.金属肽酶和蛋白酶体的顺序切割参与了HIV-1包膜蛋白表位的加工,以进行内源性MHC I类抗原呈递。
J Immunol. 2000 May 15;164(10):5070-7. doi: 10.4049/jimmunol.164.10.5070.
7
Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.通过其MHC I类结合基序鉴定出的免疫显性水貂细胞灶诱导型鼠白血病病毒(MuLV)编码的CTL表位,解释了针对MCF的细胞毒性T淋巴细胞的MuLV类型特异性。
J Immunol. 1994 Jan 1;152(1):106-16.
8
An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes.一种来自内源性嗜亲性鼠白血病病毒(MuLV)AKR623的p15E跨膜蛋白的免疫显性Kb限制性肽,该肽可恢复肿瘤细胞系对抗AKR/格罗斯MuLV细胞毒性T淋巴细胞的敏感性。
J Virol. 1994 Feb;68(2):897-904. doi: 10.1128/JVI.68.2.897-904.1994.
9
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.蛋白酶体免疫亚基或PA28的可控表达对细胞毒性T淋巴细胞表位呈递的差异影响
J Exp Med. 2000 Aug 21;192(4):483-94. doi: 10.1084/jem.192.4.483.
10
Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin.一种由RMA、EL-4和MBL-2淋巴瘤呈递的新型肿瘤特异性CTL表位的鉴定揭示了它们的共同起源。
J Immunol. 2000 Jul 15;165(2):869-77. doi: 10.4049/jimmunol.165.2.869.

引用本文的文献

1
Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8 T cells more relevant to current infections.经工程改造表达近期分离株核蛋白的活减毒流感疫苗能更有效地刺激人体针对当前感染的流感 CD8 T 细胞。
Hum Vaccin Immunother. 2018 Apr 3;14(4):941-946. doi: 10.1080/21645515.2017.1417713. Epub 2018 Jan 23.
2
Optimizing T-cell receptor gene therapy for hematologic malignancies.优化用于血液系统恶性肿瘤的T细胞受体基因疗法。
Blood. 2016 Jun 30;127(26):3305-11. doi: 10.1182/blood-2015-11-629071. Epub 2016 May 20.
3
The T210M Substitution in the HLA-a*02:01 gp100 Epitope Strongly Affects Overall Proteasomal Cleavage Site Usage and Antigen Processing.
HLA-a*02:01 gp100表位中的T210M替换强烈影响整体蛋白酶体切割位点的使用及抗原加工。
J Biol Chem. 2015 Dec 18;290(51):30417-28. doi: 10.1074/jbc.M115.695189. Epub 2015 Oct 27.
4
Mechanisms of HIV protein degradation into epitopes: implications for vaccine design.HIV蛋白降解为表位的机制:对疫苗设计的启示。
Viruses. 2014 Aug 21;6(8):3271-92. doi: 10.3390/v6083271.
5
High-frequency vaccine-induced CD8⁺ T cells specific for an epitope naturally processed during infection with Mycobacterium tuberculosis do not confer protection.高频疫苗诱导的针对结核分枝杆菌感染期间自然加工的表位的 CD8+T 细胞并不能提供保护。
Eur J Immunol. 2014 Jun;44(6):1699-709. doi: 10.1002/eji.201344358. Epub 2014 Mar 27.
6
Computational prediction of cleavage using proteasomal in vitro digestion and MHC I ligand data.基于蛋白酶体体外消化和 MHC I 配体数据的切割位点计算预测。
J Zhejiang Univ Sci B. 2013 Sep;14(9):816-28. doi: 10.1631/jzus.B1200299.
7
Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.嵌合 HIV-1 Gag 抗原可被加工并呈递给人类 HIV 特异性 CD8+ T 细胞。
J Immunol. 2011 Jun 15;186(12):6914-24. doi: 10.4049/jimmunol.1004231. Epub 2011 May 16.
8
The role of the proteasome in the generation of MHC class I ligands and immune responses.蛋白酶体在 MHC I 类配体产生和免疫反应中的作用。
Cell Mol Life Sci. 2011 May;68(9):1491-502. doi: 10.1007/s00018-011-0657-y. Epub 2011 Mar 9.
9
Functional properties and epitope characteristics of T-cells recognizing natural HIV-1 variants.识别天然HIV-1变体的T细胞的功能特性和表位特征
Vaccine. 2009 Nov 12;27(48):6678-87. doi: 10.1016/j.vaccine.2009.08.093. Epub 2009 Sep 9.
10
T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope.T细胞对HLA I类分子呈递的甲型流感病毒表位变异性的耐受性。
J Virol. 2009 Sep;83(18):9206-14. doi: 10.1128/JVI.00932-09. Epub 2009 Jun 24.